Rigel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RIGL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	294,841	1.6%
General Public	1,629,591	8.82%
Institutions	16,548,698	89.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.01%	BlackRock, Inc.	1,664,210	US$48.0m	-3.52%	no data
5.91%	State Street Global Advisors, Inc.	1,091,223	US$31.5m	96.9%	no data
5.62%	The Vanguard Group, Inc.	1,038,408	US$30.0m	-0.45%	no data
4.53%	Armistice Capital LLC	836,000	US$24.1m	15.5%	0.59%
3.32%	Marshall Wace LLP	613,600	US$17.7m	2.04%	0.02%
2.95%	LSV Asset Management	544,282	US$15.7m	391%	0.03%
2.92%	Renaissance Technologies LLC	539,009	US$15.6m	13.7%	0.02%
2.83%	Goldman Sachs Asset Management, L.P.	522,312	US$15.1m	6.97%	no data
2.67%	Acadian Asset Management LLC	493,604	US$14.3m	-28%	0.02%
2.34%	Millennium Management LLC	431,460	US$12.5m	310%	0.01%
2.3%	D. E. Shaw & Co., L.P.	424,316	US$12.3m	38.4%	0.01%
2.3%	Geode Capital Management, LLC	424,314	US$12.2m	0.14%	no data
2.24%	Arrowstreet Capital, Limited Partnership	413,659	US$11.9m	122%	0.01%
1.62%	Soleus Capital Management, L.P.	300,034	US$8.7m	-9.08%	0.36%
1.56%	Qube Research & Technologies Ltd	288,269	US$8.3m	-20.1%	0.01%
1.53%	Hillsdale Investment Management Inc.	282,584	US$8.2m	-0.64%	0.17%
1.5%	Dimensional Fund Advisors LP	276,812	US$8.0m	32.2%	no data
1.49%	Jane Street Group, LLC	275,883	US$8.0m	-14.3%	0.01%
1.47%	Two Sigma Investments, LP	271,228	US$7.8m	23.1%	0.01%
1.38%	American Century Investment Management Inc	254,492	US$7.3m	1,400%	no data
1.37%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	252,872	US$7.3m	97.7%	no data
1.22%	CM Management, LLC	225,000	US$6.5m	0%	5.06%
1.18%	GlobeFlex Capital LP	217,839	US$6.3m	0.1%	0.75%
1.07%	Trexquant Investment LP	197,148	US$5.7m	18%	0.05%
1%	Citadel Advisors LLC	185,419	US$5.4m	114%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/09 17:25
End of Day Share Price	2026/03/09 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rigel Pharmaceuticals, Inc. is covered by 20 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Birchenough	Barclays
James Birchenough	BMO Capital Markets Equity Research
Clarence Powell	BMO Capital Markets Equity Research